Literature DB >> 23456885

Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.

Tina Kroll1, David Elmenhorst, Andreas Matusch, Franziska Wedekind, Angela Weisshaupt, Simone Beer, Andreas Bauer.   

Abstract

PURPOSE: While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats. PROCEDURES: Ten Sprague Dawley rats underwent 180 min PET scans with arterial blood sampling. Reference tissue methods were evaluated on the basis of invasive kinetic models with metabolite-corrected arterial input functions. In vivo 5-HT2AR quantification with PET was validated by in vitro autoradiographic saturation experiments in the same animals. RESULT: Overall brain uptake of [18F]altanserin was reliably quantified by invasive and non-invasive models with the cerebellum as reference region shown by linear correlation of outcome parameters. Unlike in humans, no lipophilic metabolites occurred so that brain activity derived solely from parent compound. PET data correlated very well with in vitro autoradiographic data of the same animals.
CONCLUSION: [18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats. Models based on both blood input and reference tissue describe radiotracer kinetics adequately. Low cerebral tracer uptake might, however, cause restrictions in experimental usage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456885     DOI: 10.1007/s11307-013-0621-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  38 in total

1.  Strategies to improve neuroreceptor parameter estimation by linear regression analysis.

Authors:  Masanori Ichise; Hiroshi Toyama; Robert B Innis; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2002-10       Impact factor: 6.200

Review 2.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

3.  Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.

Authors:  Masanori Ichise; Jeih-San Liow; Jian-Qiang Lu; Akihiro Takano; Kendra Model; Hiroshi Toyama; Tetsuya Suhara; Kazutoshi Suzuki; Robert B Innis; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2003-09       Impact factor: 6.200

4.  Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.

Authors:  Philipp T Meyer; Zubin Bhagwagar; Philip J Cowen; Vincent J Cunningham; Paul M Grasby; Rainer Hinz
Journal:  Neuroimage       Date:  2010-01-18       Impact factor: 6.556

5.  Serotonin2A receptor-like immunoreactivity in rat cerebellar Purkinje cells.

Authors:  T Maeshima; F Shutoh; S Hamada; K Senzaki; K Hamaguchi-Hamada; R Ito; N Okado
Journal:  Neurosci Lett       Date:  1998-08-07       Impact factor: 3.046

6.  In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET.

Authors:  Kristina Fischer; Vesna Sossi; Andreas von Ameln-Mayerhofer; Gerald Reischl; Bernd J Pichler
Journal:  Neuroimage       Date:  2011-09-14       Impact factor: 6.556

7.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

8.  Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain.

Authors:  T Xu; S C Pandey
Journal:  Brain Res Bull       Date:  2000-04       Impact factor: 4.077

9.  Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.

Authors:  F Forutan; S Estalji; M Beu; S Nikolaus; K Hamacher; H H Coenen; H Vosberg; H W Müller-Gärtner; R Larisch
Journal:  Nuklearmedizin       Date:  2002       Impact factor: 1.379

10.  Region specific changes in forebrain 5-hydroxytryptamine1A and 5-hydroxytryptamine2A receptors in isolation-reared rats: an in vitro autoradiography study.

Authors:  M A Preece; J W Dalley; D E H Theobald; T W Robbins; G P Reynolds
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  4 in total

Review 1.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Radiosynthesis and Biological Evaluation of [18F]R91150, a Selective 5-HT2A Receptor Antagonist for PET-Imaging.

Authors:  Michael Willmann; Julian Hegger; Bernd Neumaier; Johannes Ermert
Journal:  ACS Med Chem Lett       Date:  2021-04-01       Impact factor: 4.345

3.  Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain.

Authors:  Tatsuya Ishii; Yasuyuki Kimura; Masanori Ichise; Keisuke Takahata; Soichiro Kitamura; Sho Moriguchi; Manabu Kubota; Ming-Rong Zhang; Makiko Yamada; Makoto Higuchi; Yoshiro Okubo; Tetsuya Suhara
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

4.  Kinetic analysis of [18F] altanserin bolus injection in the canine brain using PET imaging.

Authors:  Glenn Pauwelyn; Lise Vlerick; Robrecht Dockx; Jeroen Verhoeven; Andre Dobbeleir; Tim Bosmans; Kathelijne Peremans; Christian Vanhove; Ingeborgh Polis; Filip De Vos
Journal:  BMC Vet Res       Date:  2019-11-21       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.